| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/21/1998 | US5783560 Use of human growth hormone for preoperative administration |
| 07/21/1998 | US5783558 Treatment of bone disorders; calcium regulation |
| 07/21/1998 | US5783556 Formulated insulin-containing composition |
| 07/21/1998 | US5783216 Adjustment, removal or masking antigen |
| 07/17/1998 | CA2448630A1 Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 07/17/1998 | CA2448623A1 Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 07/17/1998 | CA2372561A1 Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 07/16/1998 | WO1998030706A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 07/16/1998 | WO1998030692A2 Human endosulfine gene |
| 07/16/1998 | WO1998030683A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/16/1998 | WO1998030586A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 07/16/1998 | WO1998030530A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 07/16/1998 | WO1998030455A2 Method and bottle for infant feeding |
| 07/16/1998 | WO1998030341A1 Film coatings and film coating compositions based on dextrin |
| 07/16/1998 | WO1998030231A1 Use of exendins and agonists thereof for the reduction of food intake |
| 07/16/1998 | WO1998030223A1 Cytokine related treatments of disease |
| 07/16/1998 | WO1998030219A1 Method for treatment of cns-involved lysosomal storage diseases |
| 07/16/1998 | WO1998019998A3 N-substituted 2-cyanopyrrolidines |
| 07/16/1998 | CA2278158A1 Cytokine related treatments of disease |
| 07/16/1998 | CA2277910A1 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 07/16/1998 | CA2277582A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 07/16/1998 | CA2276533A1 Human endosulfine gene |
| 07/15/1998 | EP0853126A2 cDNA clone HE8CS41 that encodes a human 7-transmembrane receptor |
| 07/15/1998 | EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor |
| 07/15/1998 | EP0853084A2 Substituted purine derivatives as vitronectin receptor antagonists |
| 07/15/1998 | EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof |
| 07/15/1998 | EP0852950A1 Nitrogen monoxide production suppressor |
| 07/15/1998 | EP0852948A1 Use of glycosidase inhibitor for the preparation of a medicament for the prophylaxis or treatment of malaria, endotoxic shock or septic shock |
| 07/15/1998 | EP0852618A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 07/15/1998 | EP0852469A2 Use of threonine for the treatment of phenylketonuria |
| 07/15/1998 | EP0717746B1 Phosphinic acid derivatives with anti-hyper glycemic and/or anti-obesity activity |
| 07/15/1998 | CN1187490A 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 07/15/1998 | CN1187369A Nitrogen oxide generation inhibitor |
| 07/14/1998 | US5780620 Reduced sweetness, superior stability, and appropriate viscosity |
| 07/14/1998 | US5780592 Transplant, antitumor |
| 07/14/1998 | US5780512 Alkylated (hetero) cyclic compounds |
| 07/14/1998 | US5780508 Pharmacological preparations comprising a cystine derivative |
| 07/14/1998 | US5780498 Endothelin receptor antagonists |
| 07/14/1998 | US5780490 Oxime derivatives, their preparation and their therapeutic use |
| 07/14/1998 | US5780486 Administering to treat diabetic neuropathy, migraine, neurogenic inflammation or rheumatoid arthitis |
| 07/14/1998 | US5780467 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists |
| 07/14/1998 | US5780461 Therapeutic treatment of cancer with Protein Kinase C inhibitors |
| 07/14/1998 | US5780455 Nonsettling acidic isotonic aqueous solution comprising sodium citrate, citric acid and sodium chloride |
| 07/14/1998 | US5780299 Method of altering blood sugar levels using non-transformed human pancreatic cells that have been expanded in culture |
| 07/14/1998 | US5780039 Comprising nonbitter, acidic amine salt of peptide |
| 07/14/1998 | CA2223198A1 Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract |
| 07/14/1998 | CA2127330C Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 07/14/1998 | CA2095352C Compositions containing psyllium |
| 07/10/1998 | CA2219960A1 Cdna clone he8cs41 that encodes a novel 7-transmembrane receptor |
| 07/09/1998 | WO1998029566A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029565A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029430A1 G-rich oligo aptamers and methods of modulating an immune response |
| 07/09/1998 | WO1998029415A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 07/09/1998 | WO1998029411A1 Sulfonamide compounds having 5-ht receptor activity |
| 07/09/1998 | WO1998029405A1 Substituted benzo[1,4]dioxanes as antiobesity agents |
| 07/09/1998 | WO1998029107A2 Poly(diallylamine)-based bile acid sequestrants |
| 07/09/1998 | CA2278031A1 G-rich oligo aptamers and methods of modulating an immune response |
| 07/09/1998 | CA2276394A1 Poly(diallylamine)-based bile acid sequestrants |
| 07/09/1998 | CA2275668A1 Sulfonamide compounds having 5-ht receptor activity |
| 07/09/1998 | CA2271885A1 Substituted benzo[1,4]dioxanes as antiobesity agents |
| 07/08/1998 | EP0852143A1 Stable vitamin c preparation |
| 07/08/1998 | EP0851925A1 Human growth hormone variants |
| 07/08/1998 | EP0851876A1 Antisecretory factor peptides regulating pathological permeability changes |
| 07/08/1998 | EP0851875A2 Dna sequences and secreted proteins encoded thereby |
| 07/08/1998 | EP0851865A1 Novel heterocyclic compounds |
| 07/08/1998 | EP0851763A1 Method and composition for enhanced parenteral nutrition |
| 07/08/1998 | EP0851759A1 Compounds and methods |
| 07/08/1998 | EP0754035A4 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours |
| 07/08/1998 | EP0730589B1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 07/08/1998 | EP0587815B1 Hypertonic isochloremic formulation for circulatory shock |
| 07/08/1998 | CN1187203A Method for treatment of corticosteroid induced osteopenia |
| 07/08/1998 | CN1187190A Amino acid derivatives of substituted quinoxaline 2, 3 -dione derivativesa as glutamate receptor antagonists |
| 07/08/1998 | CN1187132A Processed ginseng having enhanced pharmacological effect |
| 07/08/1998 | CN1039013C Glucopyranoside benzothiophens compounds and its preparing method and use as medicine |
| 07/08/1998 | CA2226478A1 Nitrogen monoxide production suppressor |
| 07/08/1998 | CA2210677A1 Use of glycosidase inhibitors |
| 07/07/1998 | US5776983 Antidiabetic agents, obesity, gastrointestinal disorders |
| 07/07/1998 | US5776979 Method of use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
| 07/07/1998 | US5776978 Pharmaceutical preparations containing polyunsaturated fatty acids, their esters or salts, together with antioxidant vitamins or provitamins |
| 07/07/1998 | US5776951 Anticholesterol agent |
| 07/07/1998 | US5776913 Therapeutic diet for metabolic abnormalities found in animals with lymphoma |
| 07/07/1998 | US5776906 Method for promoting fat-degradation in fat cells |
| 07/07/1998 | US5776901 Polypeptide analogues having growth hormone releasing activity |
| 07/07/1998 | US5776887 Diabetic nutritional product having controlled absorption of carbohydrate |
| 07/07/1998 | US5776753 Human peroxisomal thioesterase |
| 07/02/1998 | WO1998028445A1 Recombinant n-smases and nucleic acids encoding same |
| 07/02/1998 | WO1998028427A1 Ob fusion protein compositions and methods |
| 07/02/1998 | WO1998028414A1 Anti-obesity proteins |
| 07/02/1998 | WO1998028389A1 Substance with antiobestic and cumulative visceral fat-reducing actions and use thereof |
| 07/02/1998 | WO1998028335A1 Anti-obesity proteins |
| 07/02/1998 | WO1998028301A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/02/1998 | WO1998028292A1 Novel piperidine containing compounds |
| 07/02/1998 | WO1998028265A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 07/02/1998 | WO1998028263A1 Creatine pyruvates and method for their production |
| 07/02/1998 | WO1998027974A1 Antidiabetic agents |
| 07/02/1998 | WO1998027813A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2276149A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2276090A1 Recombinant n-smases and nucleic acids encoding same |
| 07/02/1998 | CA2275902A1 Palatable hydroxypropyl methylcellulose ether powder with specified particle size |
| 07/02/1998 | CA2275665A1 Nitromethylthiobenzene derivatives as aldose reductase inhibitors |